logo
Prognostic Value of Fluorodeoxyglucose Uptake in Non-small Cell Lung Cancer
Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
Comprehensive Molecular Analyses of Lung Adenocarcinoma with Regard to the Epidermal Growth Factor Receptor, K-ras, MET, and Hepatocyte Growth Factor Status
MEK1 and AKT2 Mutations in Japanese Lung Cancer
Pharmacokinetics of Erlotinib and Its Active Metabolite OSI-420 in Patients with Non-small Cell Lung Cancer and Chronic Renal Failure Who Are Undergoing Hemodialysis
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for Lymph Node Staging in Patients with Non-small Cell Lung Cancer in Nonoperable Patients Pursuing Radiotherapy as a Primary Treatment
Primary Tumor Standardized Uptake Value Measured on Fluorodeoxyglucose Positron Emission Tomography Is of Prognostic Value for Survival in Non-small Cell Lung Cancer
Performance Status and Smoking Status Are Independent Favorable Prognostic Factors for Survival in Non-small Cell Lung Cancer
The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients
The Influence of Sex on Efficacy, Adverse Events, Quality of Life, and Delivery of Treatment in National Cancer Institute of Canada Clinical Trials Group Non-small Cell Lung Cancer Chemotherapy Trials
CD24, a Novel Cancer Biomarker, Predicting Disease-Free Survival of Non-small Cell Lung Carcinomas
Association of the CHRNA3 Locus with Lung Cancer Risk and Prognosis in Chinese Han Population
Adjuvant Cisplatin and Docetaxel for Non-small Cell Lung Cancer
Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer
AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer
Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer
Randomized Phase II Study of Two Different Schedules of Gemcitabine and Oral S-1 in Chemo-naïve Patients with Advanced Non-small Cell Lung Cancer
A Multi-Institution Phase I/II Trial of Triweekly Regimen with S-1 Plus Cisplatin in Patients with Advanced Non-small Cell Lung Cancer
Comparison of Survival and Recurrence Pattern Between Two-Field and Three-Field Lymph Node Dissections for Upper Thoracic Esophageal Squamous Cell Carcinoma
Phase II Randomized Study of Two Regimens of Sequentially Administered Mitomycin C and Irinotecan in Patients with Unresectable Esophageal and Gastroesophageal Adenocarcinoma
Sorafenib in Patients with Advanced Non-small Cell Lung Cancer that Harbor K-Ras Mutations
Tracheal Mucoepidermoid Carcinoma
Maintenance Therapy in Advanced Non-small Cell Lung Cancer
Chemotherapy Induced Pathologic Complete Response in Malignant Pleural Mesothelioma
Biostatistics Primer
Small Cell Lung Cancer in Never Smokers
A Lung Cancer Responding to Hormonal Therapy
Cetuximab-Induced Aseptic Meningitis
Safety of Concomitant Administration of Seasonal and/or H1N1 Flu Vaccination in Patients Receiving Erlotinib for Advanced Non-small Cell Lung Cancer
Pemetrexed-Induced Fluid Retention
A Systematic Review but Systematically Confounded?
Adjuvant Chemotherapy in New Stage II pN0 Non-small Cell Lung Cancer: A New Issue for a Case-By-Case Decision Making Process
In Response:
Chest Wall Pain and Rib Fracture after Stereotactic Radiotherapy for Peripheral Non-small Cell Lung Cancer: Erratum